Edison Scientific is collaborating with investment firm Population Health Partners to utilize AI agents for accelerating drug discovery and development in the biotechnology sector. This partnership aims to harness cutting-edge AI technology to create new biotechnological solutions and enhance the efficiency of pharmaceutical research and development.
Back